Argenx price target raised to $930 from $820 at Piper Sandler

Piper Sandler raised the firm’s price target on Argenx (ARGX) to $930 from $820 and keeps an Overweight rating on the shares. The firm notes the company delivered a strong Q3 print, delivering over $1B of Vyvgart revenue in a quarter for the first time. Piper thinks the upcoming year provides multiple upside opportunities for Argenx shares through Vyvgart, with continued commercial growth and multiple expansion opportunities, not to mention opportunities from the assets in the pipeline. Argenx remains a top pick for 2025 and beyond, Piper says, adding that it remains a buyer.